Cargando…

Patent foramen ovale closure reduces recurrent stroke risk in cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials

AIM: To investigate if patent foramen ovale (PFO) closure device reduces the risk of recurrent stroke in patients with cryptogenic stroke. METHODS: We searched five databases - PubMed, EMBASE, Cochrane, CINAHL and Web-of-Science and clinicaltrials.gov from January 2000 to September 2017 for randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anantha-Narayanan, Mahesh, Anugula, Dixitha, Das, Gladwin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033706/ https://www.ncbi.nlm.nih.gov/pubmed/29983901 http://dx.doi.org/10.4330/wjc.v10.i6.41

Ejemplares similares

Percutaneous closure of a patent foramen ovale after cryptogenic stroke
por: Snijder, R. J. R., et al.
Publicado: (2017)

Closure of patent foramen ovale for secondary prevention of cryptogenic stroke: current perspectives
por: Makhija, Rakhee R., et al.
Publicado: (2019)

Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management
por: Lucà, Fabiana, et al.
Publicado: (2023)

Closure, Anticoagulation, or Antiplatelet Therapy for Cryptogenic Stroke With Patent Foramen Ovale: Systematic Review of Randomized Trials, Sequential Meta‐Analysis, and New Insights From the CLOSE Study
por: Turc, Guillaume, et al.
Publicado: (2018)

Who benefits from percutaneous closure of patent foramen ovale vs medical therapy for stroke prevention? In-depth and updated meta-analysis of randomized trials
por: Dahal, Khagendra, et al.
Publicado: (2019)

Closure or medical therapy of patent foramen ovale in cryptogenic stroke: prospective case series
por: Poli, Sven, et al.
Publicado: (2021)

Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke
por: Diener, Hans-Christoph, et al.
Publicado: (2022)

Experience in patent foramen ovale closure with the CERA Lifetech occluder in patients with cryptogenic stroke
por: Węglarz, Przemysław, et al.
Publicado: (2023)

Evaluation of Patent Foramen Ovale in Young Adults with Cryptogenic Stroke
por: Ali Ebrahimi, Hossein, et al.
Publicado: (2011)

Cryptogenic Stroke: To Close a Patent Foramen Ovale or Not to Close?
por: Kottoor, Santhosh J, et al.
Publicado: (2018)

Cryptogenic stroke and patent foramen ovale (abridged and translated version)
por: Diener, Hans-Christoph, et al.
Publicado: (2019)

Cryptogenic Ischemic Stroke in Migraine: Role of Patent Foramen Ovale
por: Gollion, Cédric, et al.
Publicado: (2022)

Patent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke prevention
por: Yuan, Kristy, et al.
Publicado: (2018)

Odyssey of Patent Foramen Ovale: Closure in Cryptogenic Stroke: The Canary in the Coal Mine of Clinical Trials?
por: Vemulapalli, Sreekanth, et al.
Publicado: (2018)

Patent foramen ovale closure in non-lacunar cryptogenic ischemic stroke: where are we now?
por: ARBOIX, Adrià, et al.
Publicado: (2021)

Device closure for patent foramen ovale in patients with cryptogenic stroke: which patients should get it?
por: Parrini, Iris, et al.
Publicado: (2020)

Decrease in shunt volume in patients with cryptogenic stroke and patent foramen ovale
por: Tanislav, Christian, et al.
Publicado: (2010)

Multidisciplinary management of patent foramen ovale (PFO) and cryptogenic stroke/TIA
por: Mirzada, Naqibullah, et al.
Publicado: (2013)

Cryptogenic Stroke and Significance of the Patent Foramen Ovale: A Case Series
por: Pour-Ghaz, Issa, et al.
Publicado: (2018)

Characteristics and prognosis of patients with cryptogenic stroke and suggestive of patent foramen ovale
por: Choi, Jaehuk, et al.
Publicado: (2021)

Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale
por: Spencer, Frederick A, et al.
Publicado: (2014)

Device closure for patent foramen ovale following cryptogenic stroke: a survey of current practice in the UK
por: Von Klemperer, Katherine, et al.
Publicado: (2017)

Cryptogenic Stroke, Patent Foramen Ovale Closure, and Mid to Long-term Outcomes: Rising Shadows of Doubt
por: Dell’Angela, Luca, et al.
Publicado: (2023)

Early Recurrent Ischemic Lesions in Patients With Cryptogenic Stroke and Patent Foramen Ovale: An Observational Study
por: Braemswig, Tim Bastian, et al.
Publicado: (2018)

Percutaneous Patent Foramen Ovale Closure After Stroke
por: Lee, Oh-Hyun, et al.
Publicado: (2022)

Patent Foramen Ovale in Cryptogenic Stroke and Migraine with Aura: Does Size Matter?
por: Sadrameli, Saeed S, et al.
Publicado: (2018)

Patent foramen ovale closure versus medical therapy for cryptogenic stroke: An updated systematic review and meta-analysis
por: Goel, Sunny, et al.
Publicado: (2019)

Percutaneous Patent Foramen Ovale Closure in Patients with Cryptogenic Stroke or Transient Ischemic Attack: A Retrospective Study
por: Liu, Yuan, et al.
Publicado: (2022)

Cost-effectiveness analysis of patent foramen ovale closure versus medical therapy alone after cryptogenic stroke
por: Shijoh, Yoko, et al.
Publicado: (2022)

Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders
por: Collado, Fareed Moses S., et al.
Publicado: (2018)

Editorial: Patent Foramen Ovale (PFO) Closure for Prevention of Stroke
por: Kokkinidis, Damianos G., et al.
Publicado: (2021)

Clinical Experience of Percutaneous Patent Foramen Ovale Closure Using the Amplatzer PFO Occluder in Japanese Patients to Prevent the Recurrence of Cryptogenic Stroke
por: Takafuji, Hiroya, et al.
Publicado: (2021)

Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence
por: Mir, Hassan, et al.
Publicado: (2018)

Increased Incidence of Interatrial Block in Younger Adults with Cryptogenic Stroke and Patent Foramen Ovale
por: Cotter, P.E., et al.
Publicado: (2011)

Cryptogenic stroke over 60 years of age: should patent foramen ovale be closed?
por: Gaspardone, Achille, et al.
Publicado: (2020)

May-Thurner Syndrome and Patent Foramen Ovale: A Rare Etiology of Cryptogenic Stroke
por: Phelps, Benjamin J, et al.
Publicado: (2019)

Comparison of Outcomes after Device Closure and Medication Alone in Patients with Patent Foramen Ovale and Cryptogenic Stroke in Korean Population
por: Moon, Jeonggeun, et al.
Publicado: (2016)

Management of patent foramen ovale in patients with cryptogenic stroke: Is device closure superior to medical treatment? A brief review
por: Sidia, Besma, et al.
Publicado: (2018)

Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials
por: Ahmad, Yousif, et al.
Publicado: (2018)

Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients
por: Han, Yangyang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jkqn7h5nh0rp4u1ns32rrafm6f